Renee Gala is President, CEO and Director of Jazz Pharmaceuticals plc (JAZZ). The company reported total compensation of $19,151,558 for fiscal year 2025.
| Salary | $1,003,269 |
|---|---|
| Bonus | $0 |
| Stock awards | $16,138,433 |
| Option awards | $0 |
| Non-equity incentive plan | $1,980,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $29,856 |
| Total | $19,151,558 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Jazz Pharmaceuticals plc filed June 8, 2026, accession 0001232524-26-000029.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, CEO and Director | $1,003,269 | $0 | $16,138,433 | $0 | $1,980,000 | $0 | $29,856 | $19,151,558 |
| FY2024 | President, CEO and Director | $824,923 | $0 | $5,079,392 | $0 | $697,000 | $0 | $27,573 | $6,628,888 |
Totals as disclosed in each year's own compensation disclosure for Jazz Pharmaceuticals plc.
| Peer-group chief executive median | $19,932,217 |
|---|---|
| Difference from that median | $-780,659 |
| Percentile within the disclosed peer group | 46th |
| Peers with a disclosed figure | 13 |
Medians and percentiles are computed across the peer group Jazz Pharmaceuticals plc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Renee Gala this page | President, CEO and Director | $19,151,558 |
| Bruce Cozadd | Chairperson and Former CEO | $18,834,836 |
| Robert Iannone | Executive Vice President, Global Head of Research and Development and Chief Medical Officer | $8,661,758 |
| Philip Johnson | Executive Vice President and CFO | $7,544,473 |
| Neena Patil | Executive Vice President and Chief Legal Officer | $6,299,539 |
| Samantha Pearce | Executive Vice President, Chief Commercial Officer | $6,076,127 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Jazz Pharmaceuticals plc compensation brief.
Renee Gala's compensation sits inside Jazz Pharmaceuticals plc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.